Essilor International SA (NASDAQ:ESLOY) has been assigned an average broker rating score of 1.00 (Strong Buy) from the two analysts that cover the company, Zacks Investment Research reports. Two investment analysts have rated the stock with a strong buy recommendation.

Brokerages have set a one year consensus price objective of $70.50 for the company, according to Zacks. Zacks has also given Essilor International SA an industry rank of 175 out of 265 based on the ratings given to related companies.

Separately, Zacks Investment Research upgraded Essilor International SA from a “sell” rating to a “buy” rating and set a $73.00 target price on the stock in a report on Tuesday, May 9th.

ILLEGAL ACTIVITY NOTICE: This report was first published by Watch List News and is owned by of Watch List News. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at

Shares of Essilor International SA (ESLOY) traded down 0.58% during mid-day trading on Friday, reaching $62.17. The company had a trading volume of 20,041 shares. Essilor International SA has a one year low of $50.35 and a one year high of $68.43.

About Essilor International SA

Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is a France-based ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals.

Get a free copy of the Zacks research report on Essilor International SA (ESLOY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Essilor International SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essilor International SA and related companies with Analyst Ratings Network's FREE daily email newsletter.